2 results
Approved WMOCompleted
The objective of the study is to assess the safety, tolerability and efficacy of PRO044.
Approved WMORecruiting
Dose escalation: To establish the MTD and RP2D of tisotumab vedotin in combination in subjects with cervical cancer Dose expansion: Evaluate the antitumor activity of tisotumab vedotin monotherapy and incombination in subjects with cervical cancer